Decade of molecular targeted therapy: Abdominal manifestations of drug toxicities - What radiologists should know

American Journal of Roentgenology

Volumn 199, Issue 1, 2012, Pages 58-64

  Howard, Stephanie Anne Holler ^a   Krajewski, Katherine M ^a   Thornton, Eavan ^a   Jagannathan, Jyothi P ^a   O'Regan, Kevin ^a   Cleary, James ^a   Ramaiya, Nikhil ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Abdominal toxicities; Bevacizumab; Drug; Molecular targeted therapy; Targeted therapy; Toxicity

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIBIOTIC AGENT; BEVACIZUMAB; ERLOTINIB; EVEROLIMUS; FLUOROURACIL; FOLINIC ACID; IMATINIB; IMMUNOMODULATING AGENT; IPILIMUMAB; IRINOTECAN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; OXALIPLATIN; PACLITAXEL; PAZOPANIB; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB;

ABSCESS; ACUTE CHOLECYSTITIS; ACUTE PANCREATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EDEMA; FATTY LIVER; FLUID RETENTION; GASTROINTESTINAL TOXICITY; HUMAN; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; RADIATION ATTENUATION; SIDE EFFECT; TOXIC HEPATITIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOLECYSTITIS; DRUG-INDUCED LIVER INJURY; EARLY DIAGNOSIS; EDEMA; FATTY LIVER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFECTION; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOPLASMS; PANCREATITIS; PROTEIN-TYROSINE KINASES; PYRIMIDINES; RADIOGRAPHY, ABDOMINAL; SULFONAMIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84863648475     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7432     Document Type: Article

References (15)

1. Skeel RT. Handbook of cancer chemotherapy. Philadelphia, PA: Lippincott Williams & Wilkins, 2007:15-27
2. Weber J. Ipilimumab: controversies in its development, utility and autoimmune adverse events. Cancer Immunol Immunother 2009; 58:823-830
3. Keisner SV, Shah SR. Pazopanib: the newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma. Drugs 2011; 71:443-454
4. Brown-Glaberman U, Swart R, Dragovich T, Bracamonte E, Kurtin S, Stopeck A. Hepatic injury associated with bevacizumab use in metastatic breast and colon caners: a review of two cases. Commun Oncol 2008; 5:539-542
5. Cohen MH, Johnson JR, Chen YF, et al. FDA approval summary: erlotinib (Tarceva) tablets. Oncologist 2005; 10:461-466 (Pubitemid 41266326)
6. Liu W, Makrauer FL, Qamar AA. Fulminant hepatic failure secondary to erlotinib. Clin Gastroenterol Hepatol 2007; 5:917-920 (Pubitemid 47127027)
7. Hamer OW, Aguirre DA, Casola G, et al. Fatty liver: imaging patterns and pitfalls. RadioGraphics 2006; 26:1637-1653
8. Kobayashi Y, Kanemitu T, Kamoto A, et al. Painless acute pancreatitis associated with sorafenib treatment: a case report. Med Oncol 2011; 28:463-465
9. Akaza H, Tsukamoto T, Murai M, et al. Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma. Jpn J Clin Oncol 2007; 37:755-762 (Pubitemid 350120299)
10. Pezzilli R, Corinaldesi R, Moselli-Labate AM. Tyrosine kinase inhibitors and acute pancreatitis. JOP 2010; 11:291-293
11. Gomez-Abuin G, Karam A, Mezzadri N, Bas CA. Acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib. Clin Genitourin Cancer 2009; 7:62-63
12. Cetin B, Coskun U, Yildiz R, et al. Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus. J Oncol Pharm Pract 2011; 17:274-278
13. de Lima Lopes G, Rocha Lima CM. Emphysematous cholecystitis in a patient with gastrointestinal stromal tumor treated with sunitinib. Pharmacotherapy 2007; 27:775-777 (Pubitemid 46700972)
14. Van Glabbeke M, Verweij J, Casali PG, et al. Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: a study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTCISG-AGITG). Eur J Cancer 2006; 42:2277-2285 (Pubitemid 44316904)
15. Lieuw-a-Fa M, Peringa J, Leeksman O, Terpstra W. Sepsis from liver abscesses in metastatic colorectal carcinoma after chemoimmunotherapy. J Clin Oncol 2008; 26:1381-1382